APOE: A risk factor for multiple disorders

American Journal of Geriatric Psychiatry

Volumn 20, Issue 7, 2012, Pages 545-548

  Myers, Amanda J ^a,b   Nemeroff, Charles B ^b,c  

^a Departments of Neurology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Center on Aging   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ALZHEIMER DISEASE; APOLIPOPROTEIN E GENE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITION; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC RISK; GENETIC VARIABILITY; HUMAN; PROTEIN BLOOD LEVEL; REVIEW;

EID: 84863518307     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/JGP.0b013e318259b9a5     Document Type: Editorial

References (28)

1. Zannis VI, Just PW, Breslow JL: Human apolipoprotein E isoprotein subclasses are genetically determined. Am J Hum Genet 1981; 33:11-24 (Pubitemid 11188459)
2. Corder EH, Saunders AM, Strimatter WJ, et al: Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 13;261(5123): 921-923
3. Donix M, Ercoli LM, Siddarth P, et al: Influence of Alzheimer's disease family history and genetic risk on cognitive performance in healthy middle-aged and older people. Am J Geriatr Psychiatry 2012; 20:565-573
4. Yasuno F, Tanimukai S, Sasaki M, et al: Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype. Am J Geriatr Psychiatry 2012; 20:574-583
5. Bonner-Jackson A, Okonkwo O, Tremont G, et al: Apolipoprotein E ε2 and functional decline in amnestic mild cognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 2012; 20:584-593
6. Gustafson D, Mazzucco S, Ongaro F, et al: Body mass index, cognition, disability, APOE genotype and mortality: the "Treviso Longeva" study. Am J Geriatr Psychiatry. 2012; 20:594-602
7. Sun Y-M, Li H-L, Guo Q-H, et al: The polymorphism of the ATPbinding cassette transporter 1 gene modulates Alzheimer disease risk in Chinese Han ethnic population. Am J Geriatr Psychiatry 2012; 20:603-611
8. Myers A, Wavrant De-Vrieze F, Holmans P, et al: A full genome screen for Alzheimer's disease: Stage 2 analysis. Am J Med Genet Neuropsych Genet 2002; 114(2):233-242
9. Clee SM, Zwinderman AH, Engert JC, et al: Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001; 103(9):1198-1205 (Pubitemid 32221340)
10. Frikke-Schmidt R. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review. Scand J Clin Lab Invest Suppl 2000; 233:3-25 (Pubitemid 32147170)
11. Klaver CWC, Kliffen M, van Duijn CM, et al: Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998; 63:200-206 (Pubitemid 30428336)
12. Krishnan KRR, Tupler LA, Ritchie JC, et al Apolipoprotein E-,4 frequency in geriatric depression. Biol Psychiatry 1996; 40:69-71
13. Hugh P, Oturai A, Schreiber K, et al: Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate. Mult Scler 2000; 6(4):226-230
14. Jordan BD, Relikin NR, Ravdin LD, et al: Apolipoprotein E ε4 associated with chronic traumatic brain injury in boxing. JAMA 1997; 278(2):136-140 (Pubitemid 27287671)
15. Slooter AJC, Tang M-X, van Duijn CM, et al: Apolipoprotein E E4 and the risk of dementia with stroke. JAMA 1997; 227(10):818-821
16. Holtzman DM, Herz J, Bu G: Apolipoprotein e and apolipoprotein e receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med 2012; 2(3):a006312
17. Utermann G, Pruin N, Steinmetz A: Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet 1979; 15:63-72 (Pubitemid 9114135)
18. Mauch DH, Nagler K, Schumacher S, et al: CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294:1354-1357 (Pubitemid 33063104)
19. Pfrieger FW. Cholesterol homeostasis and function in neurons of the central nervous system. Cell Mol Life Sci 2003; 60: 1158-1171 (Pubitemid 36791918)
20. Kivipeltp M, Helkala E-L, Laakso MP, et al: Apolipoprotein E4 allele, elevated midlife total cholesterol level and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 2002; 137:149-155 (Pubitemid 34827510)
21. Coon KD,Myers AJ, Craig DW, et al: A high density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 2007; 68(4):613-618 (Pubitemid 46663046)
22. Hutton M, Lendon CL, Rizzu P, et al: Association of missense and 5-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393(6686):702-755
23. Baker M, Mackenzie IR, Pickering-Brown SM.: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442(7105):916-919 (Pubitemid 44285946)
24. Pittman AM, Myers AJ, Duckworth J: The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum Mol Genet 2004; 13(12):1267-1274 (Pubitemid 38877880)
25. Roses AD, Lutz MW, Amrine-Madsen H, et al: A TOMM40 variablelength polymorphism predicts the age of late-onset Alzheimer's disease. Pharmacogenomics J 2010; 10(5):375-384
26. Templeton AR: A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus. Genetics 1995; 140:403-409
27. Chartier-Harlin MC, Parfitt M, Legrain S, et al: Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and lateonset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum Molec Genet 1994; 3(4):569-574
28. Yu CE, Seltman H, Peskind ER, et al: Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. Genomics 2007; 89(6):655-665 (Pubitemid 46719797)